generated: '2026-09-06'
method: searched
source: https://www.actymthera.com/
plan_count: 0
plans: []
summary: >-
  Actym Therapeutics publishes no plans, tiers or pricing of any kind. It is a clinical-stage
  biotechnology company developing bacterial immunotherapies (STACT platform, lead asset
  ACTM-838 in a Phase 1a/1b trial); it sells no software product and has no commercial API.
  Its site is six pages — home, science, pipeline, about, media, patients — plus a contact
  page and a privacy policy. The one callable surface, the Wix Site MCP endpoint, is free and
  anonymous and is provided by the site platform, not sold by Actym.
evidence:
- url: https://www.actymthera.com/sitemap.xml
  status: 200
  note: 'Full page inventory: media, science, about, pipeline, home, patients. No pricing or plans page exists.'
- url: https://www.actymthera.com/
  status: 200
  note: No pricing, plans, or purchase surface anywhere in the navigation.